Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryManagement of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusGlycaemic control for patients with acute coronary syndromeTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusDesign and implementation of GRIP: a computerized glucose control system at a surgical intensive care unitGlycaemic control for patients with acute coronary syndromeContinued efforts to translate diabetes cardiovascular outcome trials into clinical practicePersonalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfallsGlycemic variability and glycemic control in the acutely ill cardiac patientInsulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetesCardiovascular importance of hyperglycemia and hypoglycemiaManagement of diabetes mellitus type-2 in the geriatric population: Current perspectivesTargeting myocardial substrate metabolism in heart failure: potential for new therapiesImproved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care AdmissionPro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.Therapy insight: heart disease and the insulin-resistant patient.Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting.The effects of intravenous insulin infusions on early mortality for patients with acute coronary syndromes who present with hyperglycaemia: A matched propensity analysis using data from the MINAP database 2008-2012.The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial InfarctCardiac rehabilitation in patients with ST-segment elevation myocardial infarction: can its failure be predicted?Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention.Early insulin use in type 2 diabetes: what are the cons?Ultra-acute increase in blood glucose during prehospital phase is associated with worse short-term and long-term survival in ST-elevation myocardial infarction.Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society.Importance of measuring glycosylated hemoglobin in patients with myocardial infarction and known diabetes mellitus.Impact of conditioning hyperglycemic on myocardial infarction rats: Cardiac cell survival factors.Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular riskDose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure.Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.Hypoglycemia, diabetes, and cardiovascular events.Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysisBrazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBCopeptin, IGFBP-1, and cardiovascular prognosis in patients with type 2 diabetes and acute myocardial infarction: a report from the DIGAMI 2 trial.Diabetes is an independent predictor of survival 17 years after myocardial infarction: follow-up of the TRACE registry.A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction.Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study.Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis.Impact of hyperglycemia on morbidity and mortality, length of hospitalization and rates of re-hospitalization in a general hospital setting in Brazil
P2860
Q22241786-B1B5247B-E737-4DD5-B6DC-0180D6A41AB0Q22242896-158F1904-1538-427C-AADC-1294CE1CB4BFQ24186667-374EFB9B-3C41-4BF9-8BC7-D10EFB16E704Q24197696-4CEB7513-D77D-49C1-8186-3A64AE481F77Q24202505-3E2DAEDA-33B2-4AB7-AEBC-4CDA45C93B4FQ24236456-47240587-2BB7-4890-AB80-81B8B6D319B4Q25257096-A0476F7A-FBBA-4768-9BDA-8F6C937468F5Q26471811-4A6F3F02-BC48-4858-9428-FA23CC00DE27Q26741860-4E2B59A5-353D-47AE-9051-AF1F9B586DD8Q26775125-81728633-24F6-45BE-A7A2-78B372FACD95Q26821994-4D6835A8-DF89-4DCA-A6D4-8279DB961827Q26866924-03DA006D-8045-4E2A-87D1-7B7596515DC8Q26999390-6F6D0587-BE55-4D0C-AA86-68D74D35F8A1Q26999670-D2859C5C-0313-4383-B911-36CD8A7F5787Q27694733-C299634B-3530-4218-8C33-AD62F2FC28D2Q28217902-49B217AC-FC51-4CE7-AE93-F8857CFEC46EQ30234356-6775631D-DC61-4A95-9BD7-AFEC2E8CE7B7Q30351748-CB4041CF-7833-47D2-A0AB-A3A9F74BA658Q30428584-1D566228-18BF-4EA6-8480-0EE2B9F5E3ABQ30848885-69CF3049-A30B-4A12-AB0C-FBBC2A754D27Q31033137-251409FD-89A2-4816-AEEF-FA677D439C4CQ33442196-C9F52BC2-3330-43AE-BD23-E06997950393Q33600990-5BAA5972-4F34-43FA-A2F3-146626EC3972Q33610761-C1B5E524-4AC5-46D3-9594-10E50F337A4DQ33622028-52C88BF1-4846-4CE0-811B-97C4A25D6422Q33647298-5839B804-334F-4937-8601-362067A64721Q33798959-DAA181BE-4DA7-4D7D-B277-6902FDEEDCD7Q33812935-D796D4A8-0830-4859-A8E4-927A81A3BC98Q33813768-7EB64070-3DC9-42BD-BF02-C6444BF986F0Q33815573-CC4BC4E4-E853-420E-8325-376BE2F9C94FQ33834055-82BB90DC-CAB8-4182-B6BB-73049F2697C7Q33873251-57C05A0B-49D5-4D1E-A94E-1B4F70ACE7C0Q33880174-EC61610A-FEA2-42CC-9B5F-63797E92B599Q33908782-A7944A70-7DBB-4E2F-9C1C-EF45D122A57EQ33932812-8EC48BF8-32E4-42E9-A4BE-1D0853B1481BQ33945039-F87C0301-9685-43AA-93F6-3A2619B81C8AQ33967758-0C6363D2-5B0C-4C9E-907A-E874D6777E08Q33975575-64DDA537-B298-4552-B100-519B699D3BC3Q34002421-9FAC01C9-6426-491A-8423-661E2489B78BQ34031249-1C3EC00A-8747-496F-B7F4-4818557F338D
P2860
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Intense metabolic control by m ...... ts on mortality and morbidity.
@en
Intense metabolic control by m ...... nd acute myocardial infarction
@nl
type
label
Intense metabolic control by m ...... ts on mortality and morbidity.
@en
Intense metabolic control by m ...... nd acute myocardial infarction
@nl
prefLabel
Intense metabolic control by m ...... ts on mortality and morbidity.
@en
Intense metabolic control by m ...... nd acute myocardial infarction
@nl
P2093
P50
P921
P356
P1476
Intense metabolic control by m ...... ts on mortality and morbidity.
@en
P2093
C Torp-Pedersen
DIGAMI 2 Investigators
K Birkeland
K Malmberg
P304
P356
10.1093/EURHEARTJ/EHI199
P577
2005-02-23T00:00:00Z